P3 Health Partners (NASDAQ:PIII) Downgraded by BTIG Research to “Neutral”

BTIG Research downgraded shares of P3 Health Partners (NASDAQ:PIII – Free Report) from a buy rating to a neutral rating in a research note issued to investors on Monday morning, Marketbeat Ratings reports. Separately, Lake Street Capital reduced their target price on shares of P3 Health Partners from $9.00 to $4.50 and set a buy […]

Leave a Reply

Your email address will not be published.

Previous post Head to Head Contrast: New Concept Energy (NYSE:GBR) and Woodside Energy Group (NYSE:WDS)
Next post Head-To-Head Contrast: Duos Technologies Group (OTCMKTS:DUOT) versus Amplitude (NASDAQ:AMPL)